Clinical Trial Update: A Study to Evaluate the Safety, Reactogenicity and Immunogenicity of GSK Biologicals' Staphylococcal Investigational Vaccine in Healthy Adults [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial update assessing safety, reactogenicity, and immunogenicity of GlaxoSmithKline's Staphylococcal investigational vaccine in healthy adul…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Staphylococcal Infections

Drugs mentioned

• Staphylococcal investigational vaccine

Snippet

Sponsor: GlaxoSmithKline | Conditions: Infections, Staphylococcal | Phase 1 | Status: COMPLETED